Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[68Ga]-FAPI PET/CT to Detect Fibroblast Activity in Non-resolving ARDS, a Feasibility Study.

NCT06691464 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT06691464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06691464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[68Ga]-FAPI PET/CT to Detect Fibroblast Activity in Non-resolving ARDS, a Feasibility Study.
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Enrolling by invitation
Start date
September 1, 2024
Completion date
June 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ards (moderate or severe)